Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response

被引：0
|
作者：
Rossi, Giovanni [1 ]
Genova, Carlo [1 ]
Morbelli, Silvia [2 ]
Rijavec, Erka [1 ]
Barletta, Giulia [1 ]
Biello, Federica [1 ]
Maggioni, Claudia [1 ]
Mennella, Simone [3 ]
Dal Bello, Maria Giovanna [1 ]
Distefano, Roberta [1 ]
Bauckneht, Matteo [2 ]
Cittadini, Giuseppe [3 ]
Merlo, Franco [1 ]
Sambuceti, Gianmario [2 ]
Grossi, Francesco [1 ]
机构：
[1] San Martino Hosp, Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy
[2] San Martino Hosp, Natl Inst Canc Res, Nucl Med, Genoa, Italy
[3] San Martino Hosp, Natl Inst Canc Res, Radiol, Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
response evaluation; Nivolumab; PERCIST; RECIST;
D O I：
10.1016/j.jtho.2016.11.458
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA10.09
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [31] CD163 detection in immune check-point inhibitors-related acute interstitial nephritis
    Perier, Thomas
    Renaudineau, Yves
    Pellegrini, Juliette
    Colombat, Magali
    Ramirez, Angie Arango
    Guy, Pierre
    Jamme, Thibaut
    Van Acker, Nathalie
    Kounde, Clement
    Ribes, David
    Huart, Antoine
    Casemayou, Audrey
    Belliere, Julie
    CLINICAL KIDNEY JOURNAL, 2025, 18 (03)
  • [32] Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors
    Aras, Mustafa
    Erdil, Tanju Y.
    Dane, Faysal
    Gungor, Serkan
    Ones, Tunc
    Dede, Fuat
    Inanir, Sabahat
    Turoglu, Halil T.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (01) : 9 - 15
  • [33] Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases
    Ocepek, Andreja
    RADIOLOGY AND ONCOLOGY, 2024, 58 (02) : 179 - 185
  • [34] Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
    Luke, Jason John
    Ott, Patrick Alexander
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2457 - 2462
  • [35] Using serial 18F-FDG PET/CT PERCIST response to predict responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
    Ladwa, Rahul
    Kenyon, Sarrinder
    Jagger, Gillian
    McGrath, Margaret Louise
    Cuscaden, Claire
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST)
    Ding, Qiyong
    Cheng, Xu
    Yang, Lu
    Zhang, Qingbo
    Chen, Jianwei
    Li, Tiannv
    Shi, Haibin
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 677 - 683
  • [37] Comparison of EORTC criteria and PERCIST for FDG PET/CT response evaluation of patients with metastatic breast cancer treated with a first line of systemic therapy
    Depardon, E.
    Kanoun, S.
    Humbert, O.
    Riedinger, J.
    Lasserre, M.
    Toubeau, M.
    Berriolo-Riedinger, A.
    Dygai-Cochet, I.
    Fumoleau, P.
    Brunotte, F.
    Cochet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S266 - S266
  • [38] Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma
    Marwa Mohammed Hasan Tawfik
    Ahmed Mohamed Monib
    Aya Yassin
    Susan Adil Ali
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [39] Initial evaluation of the applicability of PET response criteria in solid tumors (PERCIST 1.0)
    Jacene, Heather
    Goudarzi, Behnaz
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [40] Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma
    Tawfik, Marwa Mohammed Hasan
    Monib, Ahmed Mohamed
    Yassin, Aya
    Ali, Susan Adil
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):
12345